David Welsh

Dr.

Lecturer, Biological and Biomedical Sciences

Emaildwe2@gcu.ac.uk

70 Cowcaddens Road, Glasgow Caledonian University
G4 0BA Glasgow
United Kingdom

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where David Welsh is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

2 Similar Profiles

Pulmonary Hypertension Medicine & Life Sciences

fluvastatin Medicine & Life Sciences

p38 Mitogen-Activated Protein Kinases Medicine & Life Sciences

Pulmonary Artery Medicine & Life Sciences

Lung Medicine & Life Sciences

Fibroblasts Medicine & Life Sciences

Adventitia Medicine & Life Sciences

Hydroxymethylglutaryl-CoA Reductase Inhibitors Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2007 2019

11 Article

Understanding longitudinal bi-ventricular structural and functional changes in a Pulmonary Hypertension Sugen-Hypoxia rat model by Cardiac Magnetic Resonance Imaging

Welsh, D., 5 Dec 2019, (Accepted/In press) In : Pulmonary Circulation.

Research output: Contribution to journal › Article

Pulmonary Hypertension

Magnetic Resonance Imaging

Dilatation

Rodentia

Cardiac Catheters

6 Downloads (Pure)

Short-term hemodynamic effects of apelin in patients with pulmonary arterial hypertension

Brash, L., Peacock, A., Newby, D. & Welsh, D., Apr 2018, In : JACC: Basic to Translational Science. 28, 2, p. 176-186

Research output: Contribution to journal › Article

Open Access

File

Pulmonary Hypertension

Hemodynamics

Hypertension

Type 5 Cyclic Nucleotide Phosphodiesterases

Lung

1 Downloads (Pure)

The role of microRNA-155/LXR pathway in experimental and Idiopathic Pulmonary Fibrosis

Kurowska-Stolarska, M., Hasoo, M. K., Welsh, D. J., Stewart, L., McIntyre, D., Morton, B. E., Johnstone, S., Miller, A. M., Asquith, D. L., Millar, N. L., Millar, A. B., Feghali-Bostwick, C. A., Hirani, N., Crick, P. J., Wang, Y., Griffiths, W. J., McInnes, I. B. & McSharry, C., Jun 2017, In : Journal of Allergy and Clinical Immunology. 139, 6, p. 1946-1956 11 p.

Research output: Contribution to journal › Article

Open Access

File

Idiopathic Pulmonary Fibrosis

MicroRNAs

Lung

Fibroblasts

Macrophages

The reversal of pulmonary vascular remodeling through inhibition of p38 MAPK-alpha: a potential novel anti-inflammatory strategy in pulmonary hypertension

Church, A. C., Martin, D. H., Wadsworth, R., Bryson, G., Fisher, A. J., Welsh, D. J. & Peacock, A. J., 1 Aug 2015, In : American Journal of Physiology: Lung Cellular and Molecular Physiology. 309, 4, p. L333-L347

Research output: Contribution to journal › Article

p38 Mitogen-Activated Protein Kinases

Pulmonary Hypertension

Anti-Inflammatory Agents

Lung

Vascular Diseases

Nuclear IL-33 regulates soluble ST2 receptor and IL-6 expression in primary human arterial endothelial cells and is decreased in idiopathic pulmonary arterial hypertension

Shao, D., Perros, F., Caramori, G., Meng, C., Dormuller, P., Chou, P-C., Church, C., Papi, A., Casolari, P., Welsh, D., Peacock, A., Humbert, M., Adcock, I. M. & Wort, S. J., 1 Aug 2014, In : Biochemical and Biophysical Research Communications. 451, 1, p. 8-14 7 p.

Research output: Contribution to journal › Article